<DOC>
	<DOCNO>NCT02135367</DOCNO>
	<brief_summary>The investigator hypothesize intra-articular injection Platelet-rich Plasma ( PRP ) treat knee degenerative articular cartilage pathology could determine pain relief recovery knee function overall clinical outcome comparable even good viscosupplementation , common injective approach apply kind pathology . To purpose investigator design double blind randomize control trial compare PRP v viscosupplementation . A power analysis perform primary endpoint IKDC subjective score improvement 12-month follow-up PRP . From pilot study , standard deviation 15.2 point find . With alpha error 0.05 , beta error 0.2 minimal clinically significant difference 6.7 point correspond 1/3 documented mean improvement , minimum sample size 83 group . Considering possible drop 15 % , 96 patient per group require total 192 patient , select accord well-defined inclusion criterion ( see 'Eligibility criterion ' section ) . Patients assign two different treatment group , accord randomization list . The first group treatment consist three weekly intra-articular injection autologous PRP obtain follow procedure : 150-ml autologous venous blood sample undergo 2 centrifugation ( first 1480 rpm 6 minute separate erythrocyte , second 3400 rpm 15 minute concentrate platelet ) produce 20 ml PRP . This unit PRP divide 4 small unit 5 ml . One unit send laboratory analysis platelet concentration quality test , 3 unit store -30째 C. The second treatment group consist patient receive three weekly injection hyaluronic acid ( Hyalubrix 30 mg/2ml , Fidia Farmaceutici Spa , Italy ; Molecular Weight : 1500 kDa ) . To guarantee blind patient , undergo blood harvest obtain autologous PRP use half , accord aforementioned randomization list . One week PRP production , injective treatment start , 3 weekly injection PRP HA . At moment injection syringe properly cover prevent patient discover substance receiving . After injection , patient send home instruction limit use leg least 24 h use cold therapy/ice affect area relieve pain . During period , use non-steroidal medication forbidden . Patients prospectively evaluate basally 2 , 6 , 12 month follow-up use clinical subjective score objective parameter determine clinical outcome ( see 'Outcome measure ' section ) . Patient satisfaction adverse event also report . All clinical evaluation perform medical staff involve injective procedure , order keep study double blind . At end study , nature inject substance reveal patient .</brief_summary>
	<brief_title>Platelet-rich Plasma ( PRP ) v Viscosupplementation Treatment Early Knee Articular Degenerative Pathology</brief_title>
	<detailed_description>Current research investigate new method stimulate repair replace damage cartilage . In particular , recent knowledge regard tissue biology highlight complex regulation growth factor ( GFs ) normal tissue structure reaction tissue damage . The influence GFs cartilage repair widely investigate vitro vivo . Platelet Rich Plasma ( PRP ) simple , low- cost minimally- invasive method allow one obtain natural concentrate autologous GFs blood , increasingly applied clinical practice treat knee degenerative pathology , chondropathy early OA . The biological rational PRP platelet contain storage pool GFs , cytokine , chemokines many mediators.Although widespread application , high level study literature demonstrate real efficacy PRP . In fact , present moment , knowledge publish randomize control trial compare PRP conservative treatment commonly use knee OA . The investigator hypothesize intra-articular injection PRP treat knee degenerative articular cartilage pathology could determine pain relief recovery knee function overall clinical outcome comparable even good viscosupplementation , common injective approach apply kind pathology . To purpose investigator design double blind randomize control trial compare PRP v viscosupplementation . A power analysis perform primary endpoint IKDC subjective score improvement 12-month follow-up PRP . From pilot study , standard deviation 15.2 point find . With alpha error 0.05 , beta error 0.2 minimal clinically significant difference 6.7 point correspond 1/3 documented mean improvement , minimum sample size 83 group . Considering possible drop 15 % , 96 patient per group require total 192 patient . Patients assign two different treatment group , accord randomization list . The first group treatment consist three weekly intra-articular injection autologous PRP obtain follow procedure : 150-ml autologous venous blood sample undergo 2 centrifugation ( first 1480 rpm 6 minute separate erythrocyte , second 3400 rpm 15 minute concentrate platelet ) produce 20 ml PRP . This unit PRP divide 4 small unit 5 ml . One unit send laboratory analysis platelet concentration quality test , 3 unit store -30째 C. The second treatment group consist patient receive three weekly injection hyaluronic acid ( Hyalubrix 30 mg/2ml , Fidia Farmaceutici Spa , Italy ; Molecular Weight : 1500 kDa ) . To guarantee blind patient , undergo blood harvest obtain autologous PRP use half , accord aforementioned randomization list . One week PRP production , injective treatment start , 3 weekly injection PRP HA . At moment injection syringe properly cover prevent patient discover substance receiving . After injection , patient send home instruction limit use leg least 24 h use cold therapy/ice affect area relieve pain . During period , use non-steroidal medication forbidden . Patients prospectively evaluate basally 2 , 6 , 12 month follow-up use IKDC , KOOS , EQ-VAS general health status , Tegner score . Furthermore basal evaluation every follow-up ROM transpatellar circumference index knee contralateral one measure check change occur time . Patient satisfaction adverse event also report . All clinical evaluation perform medical staff involve injective procedure , order keep study double blind . At end study , nature inject substance reveal patient .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>age range 18 55 patient affected knee articular degenerative pathology history chronic ( least 4 month ) pain swell ; image finding degenerative change joint ( Kellgren Lawrence 0 2 Xray evaluation ) . age &gt; 55 year ; KellgrenLawrence score Xray evaluation &gt; 2 ; major axial deviation ( varus &gt; 5째 , valgus &gt; 5째 ) , systemic disorder diabetes , rheumatoid arthritis , haematological disease ( coagulopathy ) , severe cardiovascular disease , infection , immunodepression ; patient therapy anticoagulant antiaggregants ; use NSAIDs 5 day blood donation ; previous intraarticular injection past 6 month blood donation ; previous knee surgery past 12 month blood donation ; patient Hb value &lt; 11 g/dl platelet value &lt; 150,000/mmc</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>PRP</keyword>
	<keyword>growth factor</keyword>
	<keyword>Viscosupplementation</keyword>
	<keyword>injection</keyword>
	<keyword>chondropathy</keyword>
	<keyword>randomize control trial</keyword>
</DOC>